CD163 and laryngotracheoesophageal cleft: Figure 2 illustrates level differences in 8 biomarkers (OPG, PTX3, AXL, ALCAM, sCD163, CD147, Cats and DLL1) between patients with COPD, LC with and without COPD and LC with COPD.